Target Price | $381.62 |
Price | $331.62 |
Potential | 15.08% |
Number of Estimates | 21 |
21 Analysts have issued a price target Sherwin-Williams 2026 . The average Sherwin-Williams target price is $381.62. This is 15.08% higher than the current stock price. The highest price target is $420.00 26.65% , the lowest is $283.00 14.66% . | |
A rating was issued by 30 analysts: 16 Analysts recommend Sherwin-Williams to buy, 11 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sherwin-Williams stock has an average upside potential 2026 of 15.08% . Most analysts recommend the Sherwin-Williams stock at Purchase. |
23 Analysts have issued a sales forecast Sherwin-Williams 2025 . The average Sherwin-Williams sales estimate is $23.6b . This is 2.39% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $24.0b 4.00% , the lowest is $23.1b 0.05% .
This results in the following potential growth metrics:
2024 | $23.1b | 0.20% |
---|---|---|
2025 | $23.6b | 2.39% |
2026 | $24.8b | 4.99% |
2027 | $26.2b | 5.64% |
2028 | $27.0b | 3.04% |
24 Analysts have issued an Sherwin-Williams EBITDA forecast 2025. The average Sherwin-Williams EBITDA estimate is $4.7b . This is 7.17% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.0b 13.75% , the lowest is $4.4b 0.25% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $4.4b | 3.63% |
---|---|---|
2025 | $4.7b | 7.33% |
2026 | $5.1b | 8.78% |
2027 | $5.6b | 9.45% |
2028 | $5.6b | 0.68% |
2024 | 19.04% | 3.42% |
---|---|---|
2025 | 19.96% | 4.82% |
2026 | 20.68% | 3.61% |
2027 | 21.43% | 3.63% |
2028 | 20.65% | 3.64% |
11 Sherwin-Williams Analysts have issued a net profit forecast 2025. The average Sherwin-Williams net profit estimate is $2.9b . This is 7.64% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.1b 15.17% , the lowest is $2.6b 3.41% .
This results in the following potential growth metrics and future Net Margins:
2024 | $2.7b | 14.05% |
---|---|---|
2025 | $2.9b | 7.64% |
2026 | $3.2b | 12.56% |
2027 | $3.7b | 14.53% |
2028 | $3.8b | 3.55% |
2024 | 11.48% | 13.82% |
---|---|---|
2025 | 12.07% | 5.16% |
2026 | 12.94% | 7.21% |
2027 | 14.03% | 8.42% |
2028 | 14.10% | 0.50% |
11 Analysts have issued a Sherwin-Williams forecast for earnings per share. The average Sherwin-Williams EPS is $11.36 . This is 7.68% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.15 15.17% , the lowest is $10.19 3.41% .
This results in the following potential growth metrics and future valuations:
2024 | $10.55 | 14.05% |
---|---|---|
2025 | $11.36 | 7.68% |
2026 | $12.78 | 12.50% |
2027 | $14.64 | 14.55% |
2028 | $15.16 | 3.55% |
Current | 31.44 | 5.07% |
---|---|---|
2025 | 29.20 | 7.12% |
2026 | 25.94 | 11.16% |
2027 | 22.65 | 12.68% |
2028 | 21.87 | 3.44% |
Based on analysts' sales estimates for 2025, the Sherwin-Williams stock is valued at an EV/Sales of 4.06 and an P/S ratio of 3.53 .
This results in the following potential growth metrics and future valuations:
Current | 4.16 | 7.49% |
---|---|---|
2025 | 4.06 | 2.36% |
2026 | 3.87 | 4.75% |
2027 | 3.66 | 5.34% |
2028 | 3.55 | 2.95% |
Current | 3.61 | 7.07% |
---|---|---|
2025 | 3.53 | 2.33% |
2026 | 3.36 | 4.75% |
2027 | 3.18 | 5.34% |
2028 | 3.09 | 2.95% |
Sherwin-Williams...
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 22 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 09 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 08 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 07 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 03 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 01 2025 |
Jefferies |
Buy
➜
Hold
|
Downgrade | Mar 10 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 22 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 09 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 08 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 07 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 03 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Apr 01 2025 |
Downgrade
Jefferies:
Buy
➜
Hold
|
Mar 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.